ArticleBasic & clinical pharmacology & toxicology2026
In Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root.
Article in Basic & clinical pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root.Basic & clinical pharmacology & toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Plant extracts are an important raw material for the development of new drugs. Rumex obtusifolius L., popularly known as 'bitter dock', has significant pharmacological properties. This study evaluated the in vitro antitrypanosomal activity of aqueous, hydroethanolic and ethanolic extracts from the leaf and roots of R. obtusifolius L. against Trypanosoma evansi, as well as their antibacterial activity against Escherichia coli and Streptococcus aureus. Antitrypanosomal assays were performed using extract concentrations of 0.5%, 1% and 2% and analysed by flow cytometry (necrosis). The antimicrobial activity was assessed at 1-100 mg/mL. Cytotoxicity was evaluated in mammalian cells for extracts active against T. evansi. The hydroethanolic and ethanolic leaf extracts exhibited significant anti-T. evansi activity, inducing necrosis rates of 64.6% and 63.7%, respectively. Besides, treatment with the ethanolic leaf extract (2%) of R. obtusifolius reduced cell viability to 14.3% after 24 h, whereas the hydroethanolic extract (2%) exhibited lower cytotoxicity, with cell viability remaining at approximately 65%-70%. None of the extracts exhibited antibacterial activity. In addition, our findings demonstrate a previously unreported pharmacological property of R. obtusifolius: the antitrypanosomal activity of its hydroethanolic and ethanolic extracts against T. evansi. Nevertheless, further studies are required to elucidate the mechanisms of action and to confirm a possible in vivo antitrypanosomal efficacy of these extracts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.